Suppr超能文献

先进技术和诊断衍生产品:采访卡尔·博雷贝克。

Advanced technologies and diagnostic spin-outs: an interview with Carl Borrebaeck.

机构信息

a Department of Immunotechnology , Lund University , Lund , Sweden.

出版信息

Expert Rev Mol Diagn. 2015;15(11):1409-10. doi: 10.1586/14737159.2015.1100499. Epub 2015 Oct 14.

Abstract

Interview with Professor Carl Borrebaeck DSc by Claire Raison (Commissioning Editor) Professor Carl Borrebaeck DSc, is the Director of CREATE Health (Lund, Sweden), a translational cancer center, previous Vice President of Lund University and specializes in immunotechnology, diagnostics and treatments for cancer. He has had remarkable success in co-founding collaborative working groups and related spin-out companies based in Lund. Professor Borrebaeck also serves as a member of the editorial advisory board for Expert Review of Molecular Diagnostics. Here, Professor Borrebaeck talks to Expert Review of Molecular Diagnostics about his experience and what is next for cutting-edge technology in cancer diagnostics.

摘要

采访教授卡尔·博雷贝克博士由克莱尔·雷森(委托编辑)进行 教授卡尔·博雷贝克博士是 CREATE Health(瑞典隆德)的主任,这是一个转化癌症中心,曾任隆德大学副校长,专注于免疫技术、癌症诊断和治疗。他在隆德成功地共同创立了合作工作组和相关的衍生公司。博雷贝克教授还担任《分子诊断专家评论》的编辑顾问委员会成员。在这里,博雷贝克教授与《分子诊断专家评论》谈论了他的经验以及癌症诊断的尖端技术的下一步发展。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验